Drug intelligence / Profile preview

radix rehmanniae

Development stage
Phase 3
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral, Topical
01

Overview

Radix rehmanniae is the dried root of *Rehmannia glutinosa*, a perennial herb native to China and widely used in Traditional Chinese Medicine (TCM) and Japanese Kampo medicine. It is most commonly employed as a tonic for "yin deficiency" and is believed in TCM to nourish the blood and kidney. The root contains various bioactive compounds including iridoid glycosides (notably catalpol), phenylethanoid glycosides (such as acteoside/verbascoside), flavonoids (e.g., quercetin-3β-D-glucoside), triterpenes and polysaccharides[6][7]. Pharmacological studies suggest that radix rehmanniae may modulate immune function and inflammation; it has demonstrated antioxidant properties and potential neuroprotective effects in animal models of Alzheimer’s disease by regulating insulin receptor signaling pathways such as INSR/IRS-1/AKT/GSK-3β[5][6]. Other research indicates possible benefits for glucose metabolism via activation of PI-3K/AKT signaling pathways[6]. In clinical practice it is used for conditions such as chronic kidney disease (CKD), anemia (“tired blood”), diabetes mellitus type 2 or insulin resistance states,[1][2] osteoporosis,[2] allergies,[4] ovarian hypofunction diseases,[7] wound healing in diabetic foot ulcers,[3] cardiovascular/cerebrovascular diseases,[7] cognitive dysfunction related to low estrogen levels or neurodegeneration.[5][7] Despite its long history of use in traditional medicine systems for a wide range of indications—including fever reduction; relief from pain/swelling; support during infections with bleeding symptoms; gynecological disorders—robust clinical evidence supporting these uses remains limited.

Brand names
Shu Di HuangChinese Foxglove
Other names
RehmanniaRehmannia glutinosaChinese foxgloveDi HuangDihuangRehmanniae RadixShu Di HuangChinese RRJapanese RRJioJuku-JioKan-JioR. GlutinosaRacine de RehmanniaRehmanniae RootRRRhemannia Root
02

Targets

GSK3 (Glycogen synthase kinase 3 beta)INSR (Insulin receptor)

Beyond the preview

Go deeper on radix rehmanniae.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on radix rehmanniae.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call